Pulmonary hypertension (PH) is a multifaceted illness causing clinical manifestations like
dyspnea, fatigue, and cyanosis. If left untreated, it often evolves into irreversible pulmonary …

In recent years, metabolomics, the systematic study of small-molecule metabolites in
biological samples, has yielded fresh insights into the molecular determinants of pulmonary …

Although PAH is partially attributed to disordered metabolism, previous human studies have
mostly examined circulating metabolites at a single time point, potentially overlooking crucial …

Pulmonary arterial hypertension (PAH) is a morbid disease characterized by significant lung
endothelial cell (EC) dysfunction. Prior work has shown that microvascular endothelial cells …

Determining asphyxia as the cause of death is crucial but is based on an exclusive strategy
because it lacks sensitive and specific morphological characteristics in forensic practice. In …

Background In PAH metabolic abnormalities in multiple pathways are well-recognized
features of right ventricular dysfunction, however, prior work has focused mainly on the use …